IRIS Accounts Production v23.3.1.45 07670478 Board of Directors 1.4.22 31.3.23 31.3.23 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh076704782022-03-31076704782023-03-31076704782022-04-012023-03-31076704782021-03-31076704782021-04-012022-03-31076704782022-03-3107670478ns14:PoundSterlingns10:Original2022-04-012023-03-3107670478ns10:Originalns10:Director12022-04-012023-03-3107670478ns10:Original2022-04-012023-03-3107670478ns10:Original2023-03-3107670478ns10:Originalns10:PrivateLimitedCompanyLtd2022-04-012023-03-3107670478ns10:Originalns10:SmallEntities2022-04-012023-03-3107670478ns10:Originalns10:AuditExempt-NoAccountantsReport2022-04-012023-03-3107670478ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2022-04-012023-03-3107670478ns10:SmallCompaniesRegimeForAccountsns10:Original2022-04-012023-03-3107670478ns10:Originalns10:FullAccounts2022-04-012023-03-3107670478ns10:Originalns10:OrdinaryShareClass12022-04-012023-03-3107670478ns10:Originalns10:Director22022-04-012023-03-3107670478ns10:Originalns10:RegisteredOffice2022-04-012023-03-3107670478ns10:Original2022-03-3107670478ns10:Originalns5:CurrentFinancialInstruments2023-03-3107670478ns10:Originalns5:CurrentFinancialInstruments2022-03-3107670478ns10:Originalns5:Non-currentFinancialInstruments2023-03-3107670478ns10:Originalns5:Non-currentFinancialInstruments2022-03-3107670478ns5:ShareCapitalns10:Original2023-03-3107670478ns5:ShareCapitalns10:Original2022-03-3107670478ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-03-3107670478ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-03-3107670478ns10:Originalns5:PlantMachinery2022-04-012023-03-3107670478ns10:Original2021-04-012022-03-3107670478ns10:Originalns5:PlantMachinery2022-03-3107670478ns10:Originalns5:PlantMachinery2023-03-3107670478ns10:Originalns5:PlantMachinery2022-03-3107670478ns10:Originalns5:CostValuation2022-03-3107670478ns10:Originalns5:AdditionsToInvestments2023-03-3107670478ns10:Originalns5:CostValuation2023-03-3107670478ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-03-3107670478ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-03-3107670478ns10:Originalns10:OrdinaryShareClass12023-03-31
REGISTERED NUMBER: 07670478












Unaudited Financial Statements

for the Year Ended 31 March 2023

for

Retinacare Consultants Limited

Retinacare Consultants Limited (Registered number: 07670478)






Contents of the Financial Statements
for the Year Ended 31 March 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Retinacare Consultants Limited

Company Information
for the Year Ended 31 March 2023







DIRECTORS: Dr H. Zambarakji
Mrs A Zambarakji





REGISTERED OFFICE: 2 Castle Business Village
Station Road
Hampton
Middlesex
TW12 2BX





REGISTERED NUMBER: 07670478





ACCOUNTANTS: PB Associates
Chartered Accountants and Chartered Tax Advisers
2 Castle Business Village
Station Road
Hampton
Middlesex
TW12 2BX

Retinacare Consultants Limited (Registered number: 07670478)

Balance Sheet
31 March 2023

31.3.23 31.3.22
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 3 56,582 66,191
Investments 4 300,000 200,000
356,582 266,191

CURRENT ASSETS
Debtors 5 106,541 158,765
Cash at bank and in hand 246,284 164,587
352,825 323,352
CREDITORS
Amounts falling due within one year 6 88,044 79,148
NET CURRENT ASSETS 264,781 244,204
TOTAL ASSETS LESS CURRENT
LIABILITIES

621,363

510,395

CREDITORS
Amounts falling due after more than one
year

7

22,641

26,597
NET ASSETS 598,722 483,798

CAPITAL AND RESERVES
Called up share capital 8 100 100
Retained earnings 598,622 483,698
SHAREHOLDERS' FUNDS 598,722 483,798

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Retinacare Consultants Limited (Registered number: 07670478)

Balance Sheet - continued
31 March 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 9 March 2024 and were signed on its behalf by:





Dr H. Zambarakji - Director


Retinacare Consultants Limited (Registered number: 07670478)

Notes to the Financial Statements
for the Year Ended 31 March 2023

1. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 25% on cost and 20% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

2. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2022 - 1 ) .

Retinacare Consultants Limited (Registered number: 07670478)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2023

3. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 April 2022 109,572
Additions 2,218
At 31 March 2023 111,790
DEPRECIATION
At 1 April 2022 43,381
Charge for year 11,827
At 31 March 2023 55,208
NET BOOK VALUE
At 31 March 2023 56,582
At 31 March 2022 66,191

4. FIXED ASSET INVESTMENTS
Other
investments
£   
COST
At 1 April 2022 200,000
Additions 100,000
At 31 March 2023 300,000
NET BOOK VALUE
At 31 March 2023 300,000
At 31 March 2022 200,000

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.23 31.3.22
£    £   
Trade debtors 76,318 35,547
Other debtors 30,223 123,218
106,541 158,765

Retinacare Consultants Limited (Registered number: 07670478)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2023

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.23 31.3.22
£    £   
Hire purchase contracts 3,955 3,955
Trade creditors 1 1
Taxation and social security 61,177 67,542
Other creditors 22,911 7,650
88,044 79,148

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN
ONE YEAR
31.3.23 31.3.22
£    £   
Hire purchase contracts 22,641 26,597

8. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.3.23 31.3.22
value: £    £   
100 Ordinary £1 100 100